episodes of worsened congestive heart failure severe enough to mandate termination of double-blind treatment were as frequent in patients taking placebo ( 4 [ 18 % ] of 21 ) as in those taking amrinone ( 4 [ 13 % ] of 31 ; p = ns ) .
C0018802
congestive heart failure
C0002697
amrinone